Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Co-Principal Investigator
P2.36: Nivolumab (nivo) in Patients (pts) With Advanced (adv) NSCLC and Central Nervous System (CNS) Metastases (mets): Track: Immunotherapy.
The inherent cellular radiosensitivity of epithelial ovarian carcinoma.
Tracheomediastinal Fistula: Rare Complication of Treatment with Bevacizumab.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (5)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Institution
Department
Faculty Rank
Name
Institution
Why
Mark Siegler
University of Chicago
Why?
Wendy Levinson
University of Chicago
Why?
Daniel West
University of Chicago
Why?
David Meltzer
University of Chicago
Why?
Daniel Sulmasy
University of Chicago
Why?
Per Page
15
25
50
100
Page
of 1
Next
Prev
Search Criteria
Decision Making Organizational
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions